Percutaneous MitraClipTM Device or Surgical Mitral Valve REpair in PAtients with PrImaRy MItral Regurgitation who are Candidates for Surgery (REPAIR-MR)

Brief description of study

REPAIR-MR is a prospective, multicenter, randomized, controlled, clinical trial of the MitraClip™ device in subjects with severe primary MR whose mitral valve has been determined to be suitable for correction by MV repair surgery by the cardiac surgeon on the local site heart team. The trial will randomize approximately 500 eligible subjects at up to 60 sites, in a 1:1 ratio to receive either: • The MitraClip™ device (Device Group): Subjects will undergo implantation with the MitraClip™ device, or • Mitral Valve Repair Surgery (Control Group): Subjects will undergo mitral valve repair surgery


Clinical Study Identifier: s20-00289
ClinicalTrials.gov Identifier: NCT04198870
Principal Investigator: Mathew R. Williams.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.